Mitsubishi UFJ Trust & Banking
VRTX icon

Mitsubishi UFJ Trust & Banking’s Vertex Pharmaceuticals VRTX Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$66.9M Sell
150,353
-11,545
-7% -$5.14M 0.16% 148
2025
Q1
$78.5M Sell
161,898
-9,708
-6% -$4.71M 0.2% 105
2024
Q4
$69.1M Sell
171,606
-13,507
-7% -$5.44M 0.16% 133
2024
Q3
$86.1M Sell
185,113
-5,015
-3% -$2.33M 0.2% 108
2024
Q2
$89.1M Sell
190,128
-23,462
-11% -$11M 0.21% 100
2024
Q1
$89.3M Sell
213,590
-16,028
-7% -$6.7M 0.2% 113
2023
Q4
$93.4M Buy
229,618
+20,090
+10% +$8.17M 0.22% 111
2023
Q3
$72.9M Sell
209,528
-7,080
-3% -$2.46M 0.18% 126
2023
Q2
$76.2M Sell
216,608
-6,671
-3% -$2.35M 0.18% 131
2023
Q1
$70.3M Sell
223,279
-11,693
-5% -$3.68M 0.17% 140
2022
Q4
$67.9M Sell
234,972
-8,809
-4% -$2.54M 0.18% 137
2022
Q3
$70.6M Sell
243,781
-34,409
-12% -$9.96M 0.2% 122
2022
Q2
$78.4M Buy
278,190
+32,446
+13% +$9.14M 0.2% 118
2022
Q1
$64.1M Sell
245,744
-9,025
-4% -$2.36M 0.15% 157
2021
Q4
$55.9M Sell
254,769
-17,977
-7% -$3.95M 0.12% 199
2021
Q3
$49.5M Buy
272,746
+1,643
+0.6% +$298K 0.11% 216
2021
Q2
$54.6M Buy
271,103
+7,140
+3% +$1.44M 0.12% 205
2021
Q1
$56.9M Sell
263,963
-63,204
-19% -$13.6M 0.13% 205
2020
Q4
$77.3M Buy
327,167
+78,637
+32% +$18.6M 0.16% 162
2020
Q3
$67.6M Buy
248,530
+3,888
+2% +$1.06M 0.15% 160
2020
Q2
$71M Buy
244,642
+34,547
+16% +$10M 0.17% 144
2020
Q1
$50M Buy
210,095
+14,035
+7% +$3.34M 0.15% 161
2019
Q4
$42.9M Sell
196,060
-311
-0.2% -$68.1K 0.1% 223
2019
Q3
$32.8M Sell
196,371
-2,995
-2% -$500K 0.08% 278
2019
Q2
$35.6M Sell
199,366
-42,783
-18% -$7.64M 0.12% 204
2019
Q1
$44.2M Sell
242,149
-93,050
-28% -$17M 0.16% 133
2018
Q4
$55.5M Sell
335,199
-5,624
-2% -$932K 0.23% 97
2018
Q3
$65.7M Sell
340,823
-327,920
-49% -$63.2M 0.23% 100
2018
Q2
$114M Buy
668,743
+5,577
+0.8% +$948K 0.19% 115
2018
Q1
$108M Buy
663,166
+2,351
+0.4% +$383K 0.19% 119
2017
Q4
$99M Buy
660,815
+425
+0.1% +$63.7K 0.17% 133
2017
Q3
$100M Buy
660,390
+2,035
+0.3% +$309K 0.19% 128
2017
Q2
$84.8M Buy
658,355
+635
+0.1% +$81.8K 0.16% 142
2017
Q1
$71.9M Sell
657,720
-3,485
-0.5% -$381K 0.14% 163
2016
Q4
$48.7M Buy
661,205
+156,647
+31% +$11.5M 0.1% 233
2016
Q3
$44M Buy
504,558
+6,751
+1% +$589K 0.09% 262
2016
Q2
$42.8M Buy
497,807
+16,317
+3% +$1.4M 0.09% 259
2016
Q1
$38.3M Buy
481,490
+5,169
+1% +$411K 0.09% 268
2015
Q4
$59.9M Buy
476,321
+2,027
+0.4% +$255K 0.14% 171
2015
Q3
$49.4M Buy
474,294
+10,537
+2% +$1.1M 0.12% 199
2015
Q2
$57.3M Buy
463,757
+8,962
+2% +$1.11M 0.13% 187
2015
Q1
$53.7M Buy
454,795
+19,581
+4% +$2.31M 0.12% 204
2014
Q4
$51.7M Buy
435,214
+12,557
+3% +$1.49M 0.12% 204
2014
Q3
$47.5M Sell
422,657
-19,186
-4% -$2.15M 0.12% 209
2014
Q2
$41.8M Buy
441,843
+3,003
+0.7% +$284K 0.1% 255
2014
Q1
$31M Buy
438,840
+6,774
+2% +$479K 0.08% 311
2013
Q4
$32.1M Buy
432,066
+12,446
+3% +$925K 0.08% 292
2013
Q3
$31.8M Buy
419,620
+7,423
+2% +$563K 0.08% 278
2013
Q2
$33M Buy
+412,197
New +$33M 0.09% 258